Cannabinoid Replacement Therapy (CRT): Nabiximols (Sativex) as a Novel Treatment for Cannabis Withdrawal

Clinical Pharmacology and Therapeutics

Volumn 97, Issue 6, 2015, Pages 571-574

  Lintzeris, N ^b,f   Copeland, J ^c   Dunlop, A ^d,e   McGregor, I S ^a   Allsop, D J ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d Hunter New England Local Health District   (Australia)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABIS; NABIXIMOLS; CANNABIDIOL; DRONABINOL; DRUG COMBINATION;

ARTICLE; CANNABIS ADDICTION; CLINICAL PRACTICE; HUMAN; PRIORITY JOURNAL; SUBSTITUTION THERAPY; WITHDRAWAL SYNDROME; DRUG COMBINATION; MARIJUANA ABUSE; SUBSTANCE WITHDRAWAL SYNDROME;

CANNABIDIOL; DRONABINOL; DRUG COMBINATIONS; HUMANS; MARIJUANA ABUSE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84938937531     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/cpt.109     Document Type: Article

References (5)

1. Allsop, D.J. et al. Nabiximols as an agonist replacement therapy during cannabis withdrawal: A randomized clinical trial. JAMA Psychiatry 71, 281-291 (2014).
2. Degenhardt, L. et al. The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: Results from the GBD 2010 Study. PLoS One 8, e76635 (2013).
3. Allsop, D.J., Norberg, M.M., Copeland, J., Fu, S. & Budney, A.J. The cannabis withdrawal scale development: Patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend. 119, 123-129 (2011).
4. Marshall, K., Gowing, L., Ali, R., Le Foll, B. Pharmacotherapies for cannabis dependence. Cochrane Database Syst. Rev. 12, Cd008940 (2014).
5. Schoedel, K.A. et al. A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use. Hum. Psychopharmacol. 26, 224-236 (2011).